These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1324519)

  • 1. Using the virus challenge dose in the analysis of virus neutralization assays.
    Parker RA; Pallansch MA
    Stat Med; 1992 Jun; 11(9):1253-62. PubMed ID: 1324519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparability of poliovirus neutralizing antibody tests.
    Wood DJ; Heath AB
    Biologicals; 1992 Dec; 20(4):293-300. PubMed ID: 1339040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified radial-plaque-neutralization test for demonstration of enterovirus neutralizing antibodies.
    Nagy G; Takátsy S
    Arch Virol; 1980; 65(2):89-98. PubMed ID: 6252870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of poliovirus neutralizing antibody tests.
    Albrecht P; van Steenis G; van Wezel AL; Salk J
    Rev Infect Dis; 1984; 6 Suppl 2():S540-4. PubMed ID: 6330853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated microtransfer technique for the assay of poliovirus- and mumps virus-neutralizing antibodies.
    Mayner RE; McDorman DJ; Meyer BC; Parkman PD
    Appl Microbiol; 1974 Dec; 28(6):968-71. PubMed ID: 4375437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments.
    Hraber P; Rademeyer C; Williamson C; Seaman MS; Gottardo R; Tang H; Greene K; Gao H; LaBranche C; Mascola JR; Morris L; Montefiori DC; Korber B
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28747500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of antipoliovirus monoclonal antibodies as an improved safety test for oral live poliomyelitis vaccine.
    Horie H; Sato M; Doi Y; Hashizume S
    Vaccine; 1996 Jan; 14(1):35-41. PubMed ID: 8821647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex PCR-Based Neutralization (MPBN) Assay for Titers Determination of the Three Types of Anti-Poliovirus Neutralizing-Antibodies.
    Manukyan H; Petrovskaya S; Chumakov K; Laassri M
    Vaccines (Basel); 2020 Mar; 8(1):. PubMed ID: 32150852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human monoclonal antibodies that neutralize multiple poliovirus serotypes.
    Puligedda RD; Kouiavskaia D; Al-Saleem FH; Kattala CD; Nabi U; Yaqoob H; Bhagavathula VS; Sharma R; Chumakov K; Dessain SK
    Vaccine; 2017 Oct; 35(41):5455-5462. PubMed ID: 28343771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies.
    Fournier C; Duverlie G; François C; Schnuriger A; Dedeurwaerder S; Brochot E; Capron D; Wychowski C; Thibault V; Castelain S
    Virol J; 2007 Mar; 4():35. PubMed ID: 17397531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.
    Taniguchi K; Urasawa S
    Arch Virol; 1987; 92(1-2):27-40. PubMed ID: 2432854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single, continuous metric to define tiered serum neutralization potency against HIV.
    Hraber P; Korber B; Wagh K; Montefiori D; Roederer M
    Elife; 2018 Jan; 7():. PubMed ID: 29350181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A micrometabolic inhibition test for the estimation of poliovirus neutralizing antibodies.
    Kyriazopoulou VG; Bell EJ
    Bull World Health Organ; 1972; 47(2):171-5. PubMed ID: 4345395
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Sutton TC; Lamirande EW; Bock KW; Moore IN; Koudstaal W; Rehman M; Weverling GJ; Goudsmit J; Subbarao K
    J Virol; 2017 Dec; 91(24):. PubMed ID: 29046448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors.
    Dhillon AK; Donners H; Pantophlet R; Johnson WE; Decker JM; Shaw GM; Lee FH; Richman DD; Doms RW; Vanham G; Burton DR
    J Virol; 2007 Jun; 81(12):6548-62. PubMed ID: 17409160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA).
    Uhlig H; Rutter G; Dernick R
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2809-12. PubMed ID: 6198443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plaque-reduction assays for human and simian immunodeficiency virus neutralization.
    Nordqvist A; Fenyö EM
    Methods Mol Biol; 2005; 304():273-85. PubMed ID: 16061983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel Newcastle disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein.
    Chumbe A; Izquierdo-Lara R; Calderón K; Fernández-Díaz M; Vakharia VN
    Virol J; 2017 Nov; 14(1):232. PubMed ID: 29169354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of primary human immunodeficiency virus type 1 isolates: a study of parameters implicated in neutralization in vitro.
    Moog C; Spenlehauer C; Fleury H; Heshmati F; Saragosti S; Letourneur F; Kirn A; Aubertin AM
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):19-27. PubMed ID: 8989423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry.
    Icenogle J; Shiwen H; Duke G; Gilbert S; Rueckert R; Anderegg J
    Virology; 1983 Jun; 127(2):412-25. PubMed ID: 6306918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.